This is a Validated Antibody Database (VAD) review about human MLANA, based on 42 published articles (read how Labome selects the articles), using MLANA antibody in all methods. It is aimed to help Labome visitors find the most suited MLANA antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
MLANA synonym: MART-1; MART1

Abcam
mouse monoclonal (HMB45 + M2-7C10 + M2-9E3)
  • immunohistochemistry; mouse; 1:200; loading ...; fig s1a
Abcam MLANA antibody (Abcam, ab732) was used in immunohistochemistry on mouse samples at 1:200 (fig s1a). Cancers (Basel) (2021) ncbi
mouse monoclonal (A103 + M2-7C10 + M2-9E3)
  • immunocytochemistry; dogs; 1:150; fig 3c
Abcam MLANA antibody (Abcam, A103-M27C10-M29E3) was used in immunocytochemistry on dogs samples at 1:150 (fig 3c). Animals (Basel) (2021) ncbi
mouse monoclonal (A103-M27C10-M29E3)
  • immunocytochemistry; dogs; 1:150; fig 3c
Abcam MLANA antibody (Abcam, A103-M27C10-M29E3) was used in immunocytochemistry on dogs samples at 1:150 (fig 3c). Animals (Basel) (2021) ncbi
mouse monoclonal (A103-M27C10-M29E3)
  • western blot; human; loading ...; fig 2b
Abcam MLANA antibody (Abcam, ab200544) was used in western blot on human samples (fig 2b). J Exp Clin Cancer Res (2021) ncbi
domestic rabbit monoclonal (EPR20380)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1e
Abcam MLANA antibody (Abcam, ab210546) was used in immunohistochemistry - paraffin section on human samples (fig 1e). Front Endocrinol (Lausanne) (2019) ncbi
mouse monoclonal (M2-9E3)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 6a
Abcam MLANA antibody (Abcam, ab187369) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 6a). Am J Hum Genet (2018) ncbi
domestic rabbit monoclonal (EP1422Y)
  • immunocytochemistry; human; 1:200; loading ...; fig 6g
  • western blot; human; 1:200
In order to study the function of the RAB6 secretory pathway melanosome formation and maturation, Abcam MLANA antibody (Abcam, EP1422Y) was used in immunocytochemistry on human samples at 1:200 (fig 6g) and in western blot on human samples at 1:200. Nat Commun (2017) ncbi
domestic rabbit monoclonal (EP1422Y)
  • immunohistochemistry; human; loading ...; fig s6b
In order to use CD49a expression to define subsets of tissue-resident memory T cells in the skin, Abcam MLANA antibody (Abcam, EP1422Y) was used in immunohistochemistry on human samples (fig s6b). Immunity (2017) ncbi
mouse monoclonal (HMB45 + M2-7C10 + M2-9E3)
  • flow cytometry; human; fig 1
Abcam MLANA antibody (Abcam, AB-ab732) was used in flow cytometry on human samples (fig 1). Oncotarget (2015) ncbi
domestic rabbit monoclonal (EP1422Y)
  • immunohistochemistry - frozen section; human
Abcam MLANA antibody (Abcam, ab51061) was used in immunohistochemistry - frozen section on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (DT101 + BC199)
  • immunohistochemistry - paraffin section; human; 1:20
Abcam MLANA antibody (Abcam, ab731) was used in immunohistochemistry - paraffin section on human samples at 1:20. Cell Transplant (2014) ncbi
Santa Cruz Biotechnology
mouse monoclonal (A103)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 1b, 1c
Santa Cruz Biotechnology MLANA antibody (Santa Cruz, A103) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1b, 1c). J Extracell Vesicles (2020) ncbi
mouse monoclonal (A103)
  • flow cytometry; mouse; loading ...; fig 2c
  • flow cytometry; human; loading ...; fig 3a
Santa Cruz Biotechnology MLANA antibody (Santa Cruz, A103) was used in flow cytometry on mouse samples (fig 2c) and in flow cytometry on human samples (fig 3a). Front Immunol (2019) ncbi
mouse monoclonal (A103)
  • western blot; zebrafish ; 1:1000; loading ...; fig ex1a
Santa Cruz Biotechnology MLANA antibody (Santa, sc-20032) was used in western blot on zebrafish samples at 1:1000 (fig ex1a). Nature (2018) ncbi
mouse monoclonal (D-1)
  • immunohistochemistry; human; 1:500; fig 3
Santa Cruz Biotechnology MLANA antibody (Santa Cruz Biotechnology, sc-271432) was used in immunohistochemistry on human samples at 1:500 (fig 3). Oncol Lett (2016) ncbi
mouse monoclonal (A103)
  • immunohistochemistry - frozen section; mouse
In order to examine the role of keratin 76 in tight junction function and maintenance of the skin barrier, Santa Cruz Biotechnology MLANA antibody (Santa Cruz Biotechnology, sc-20032) was used in immunohistochemistry - frozen section on mouse samples . PLoS Genet (2014) ncbi
mouse monoclonal (A103)
  • western blot; mouse; fig 2
In order to investigate if and how mTOR regulates YAP, Santa Cruz Biotechnology MLANA antibody (Santa Cruz Biotechnology, sc-20032) was used in western blot on mouse samples (fig 2). J Exp Med (2014) ncbi
Invitrogen
mouse monoclonal (M2-7C10)
  • immunocytochemistry; human; 1:40; loading ...; fig 4g
In order to study the function of the RAB6 secretory pathway melanosome formation and maturation, Invitrogen MLANA antibody (Thermo fisher scientific, M2-7C10) was used in immunocytochemistry on human samples at 1:40 (fig 4g). Nat Commun (2017) ncbi
mouse monoclonal (A103)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; tbl 2
In order to characterize eight cases of renal cell carcinoma cases with NONO-TFE3, Invitrogen MLANA antibody (NeoMarkers, A103/M2-72) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). Mod Pathol (2017) ncbi
mouse monoclonal (A103)
  • immunohistochemistry; human; 1:100; fig 6
In order to present two cases of primary sclerosing epithelioid fibrosarcoma of the kidney, Invitrogen MLANA antibody (Thermo, A103) was used in immunohistochemistry on human samples at 1:100 (fig 6). Diagn Pathol (2015) ncbi
mouse monoclonal (A103)
  • western blot; mouse
In order to determine which HDAC to target to specifically inhibit metastatic melanoma, Invitrogen MLANA antibody (Thermo Scientific, MS-799-P0) was used in western blot on mouse samples . Mol Oncol (2015) ncbi
mouse monoclonal (A103)
  • immunohistochemistry - paraffin section; human; 1:100
In order to describe three cases of perivascular epithelioid cell tumors with transcription factor E3 gene abnormalities, Invitrogen MLANA antibody (NeoMarkers, A103/M2-72) was used in immunohistochemistry - paraffin section on human samples at 1:100. Virchows Arch (2014) ncbi
mouse monoclonal (A103)
  • immunohistochemistry - paraffin section; human
In order to investigate the polypoid PEComa in the gastrointestinal tract, Invitrogen MLANA antibody (Zymed laboratories, A103/M2-7C10/M2-9E3) was used in immunohistochemistry - paraffin section on human samples . Am J Surg Pathol (2009) ncbi
mouse monoclonal (M2-7C10)
  • immunohistochemistry - paraffin section; human
In order to investigate the polypoid PEComa in the gastrointestinal tract, Invitrogen MLANA antibody (Zymed laboratories, A103/M2-7C10/M2-9E3) was used in immunohistochemistry - paraffin section on human samples . Am J Surg Pathol (2009) ncbi
BioLegend
mouse monoclonal (M2-7C10)
  • immunohistochemistry - paraffin section; human; loading ...; fig s1
BioLegend MLANA antibody (COVANCE, M2-7C10) was used in immunohistochemistry - paraffin section on human samples (fig s1). J Dermatol Sci (2017) ncbi
mouse monoclonal (M2-7C10)
  • immunohistochemistry; human
BioLegend MLANA antibody (Covance, SIG-38160-1000) was used in immunohistochemistry on human samples . Clin Cancer Res (2013) ncbi
Abnova
domestic rabbit monoclonal (A19-P)
  • immunohistochemistry - frozen section; human; fig 3d
In order to maintain primary human epithelial cell sheets cultured without dermal equivalents for at least 1 year, Abnova MLANA antibody (Abnova, MAB1656) was used in immunohistochemistry - frozen section on human samples (fig 3d). Sci Rep (2017) ncbi
Dako
mouse monoclonal (A103)
  • flow cytometry; human
Dako MLANA antibody (Dako, A103) was used in flow cytometry on human samples . J Immunother Cancer (2020) ncbi
mouse monoclonal (A103)
  • immunocytochemistry; mouse; 1:75; loading ...; fig 2d
  • western blot; mouse; 1:750; loading ...; fig 2b
  • western blot; human; loading ...; fig 3c
Dako MLANA antibody (Dako, A103) was used in immunocytochemistry on mouse samples at 1:75 (fig 2d), in western blot on mouse samples at 1:750 (fig 2b) and in western blot on human samples (fig 3c). Front Immunol (2019) ncbi
mouse monoclonal (A103)
  • immunohistochemistry - paraffin section; mouse; 1:50; loading ...; fig st11
  • immunohistochemistry - paraffin section; cat; loading ...; fig st11
  • immunohistochemistry - paraffin section; rat; 1:50; loading ...; fig st11
  • immunohistochemistry - paraffin section; bovine; loading ...; fig st11
  • immunohistochemistry - paraffin section; dogs; 1:50; loading ...; fig st11
In order to outline the protocols for antibodies used for immunohistochemical studies, Dako MLANA antibody (Dako, M7196) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig st11), in immunohistochemistry - paraffin section on cat samples (fig st11), in immunohistochemistry - paraffin section on rat samples at 1:50 (fig st11), in immunohistochemistry - paraffin section on bovine samples (fig st11) and in immunohistochemistry - paraffin section on dogs samples at 1:50 (fig st11). J Toxicol Pathol (2017) ncbi
mouse monoclonal (A103)
  • immunohistochemistry; human; 1:100
Dako MLANA antibody (DAKO, A103) was used in immunohistochemistry on human samples at 1:100. Diagn Pathol (2016) ncbi
mouse monoclonal (A103)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...
In order to determine the contribution of lymphatic drainage to tumor inflammation and immunity, Dako MLANA antibody (Dako, A103) was used in immunohistochemistry - paraffin section on human samples at 1:50. J Clin Invest (2016) ncbi
mouse monoclonal (A103)
  • immunohistochemistry - paraffin section; human; fig 1
Dako MLANA antibody (Dako, M7196) was used in immunohistochemistry - paraffin section on human samples (fig 1). Genome Biol (2016) ncbi
mouse monoclonal (A103)
  • flow cytometry; human; 4800 ng/ml; fig 5
Dako MLANA antibody (Dako, M7196) was used in flow cytometry on human samples at 4800 ng/ml (fig 5). PLoS ONE (2016) ncbi
mouse monoclonal (A103)
  • immunohistochemistry - paraffin section; human; fig 1c
In order to develop a patient-derived xenograft platform and use it to identify genes that contribute the cancer resistance of melanoma patients treated with BRAF inhibitors, Dako MLANA antibody (DakoCytomation, M719629) was used in immunohistochemistry - paraffin section on human samples (fig 1c). Cell Rep (2016) ncbi
mouse monoclonal (A103)
  • immunohistochemistry - paraffin section; human; fig 2
Dako MLANA antibody (Dako, M7196) was used in immunohistochemistry - paraffin section on human samples (fig 2). Oncotarget (2016) ncbi
mouse monoclonal (A103)
  • immunohistochemistry - paraffin section; human; 1:50; tbl 2
Dako MLANA antibody (Dako, A103) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 2). Am J Surg Pathol (2016) ncbi
mouse monoclonal (A103)
  • immunohistochemistry; human
Dako MLANA antibody (Dako, M7196) was used in immunohistochemistry on human samples . J Invest Dermatol (2015) ncbi
mouse monoclonal (A103)
  • immunohistochemistry - paraffin section; human; 1:50
In order to investigate PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma, Dako MLANA antibody (Dako, A103) was used in immunohistochemistry - paraffin section on human samples at 1:50. Nat Genet (2014) ncbi
mouse monoclonal (A103)
  • immunohistochemistry - paraffin section; human; 1:100
Dako MLANA antibody (Dako, M7196) was used in immunohistochemistry - paraffin section on human samples at 1:100. Br J Dermatol (2014) ncbi
mouse monoclonal (A103)
  • immunohistochemistry; dogs; 1:50
Dako MLANA antibody (Dako A/S, A103) was used in immunohistochemistry on dogs samples at 1:50. J Comp Pathol (2014) ncbi
mouse monoclonal (A103)
  • immunohistochemistry; human; 1:100; tbl 3
In order to measure the rate of concurrent ocular surface diseases in patients with pterygia, Dako MLANA antibody (DAKO, M7196) was used in immunohistochemistry on human samples at 1:100 (tbl 3). Am J Pathol (2011) ncbi
mouse monoclonal (A103)
  • immunohistochemistry - paraffin section; human
In order to study the expression of Her2 and EGFR in anorectal melanoma, Dako MLANA antibody (DAKO, A103) was used in immunohistochemistry - paraffin section on human samples . Melanoma Res (2010) ncbi
Leica Biosystems
monoclonal (A103)
  • immunohistochemistry; human; 1:100
Leica Biosystems MLANA antibody (Novocastra Laboratories, A103) was used in immunohistochemistry on human samples at 1:100. Int J Clin Exp Pathol (2015) ncbi
monoclonal (A103)
  • immunohistochemistry - paraffin section; human
In order to describe an unusual case of a recurrent dural neoplasm, Leica Biosystems MLANA antibody (Novocastra, A103) was used in immunohistochemistry - paraffin section on human samples . Hum Pathol (2015) ncbi
monoclonal (A103)
  • immunohistochemistry - paraffin section; human
Leica Biosystems MLANA antibody (Novocastra Laboratories, A103) was used in immunohistochemistry - paraffin section on human samples . Oncol Lett (2014) ncbi
Articles Reviewed
  1. Catalano A, Adlesic M, Kaltenbacher T, Klar R, Albers J, Seidel P, et al. Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition. Cancers (Basel). 2021;13: pubmed publisher
  2. Sforna M, Chiaradia E, Porcellato I, Silvestri S, Moretti G, Mechelli L, et al. Characterization of Primary Cultures of Normal and Neoplastic Canine Melanocytes. Animals (Basel). 2021;11: pubmed publisher
  3. Sánchez del Campo L, Martí Díaz R, Montenegro M, González Guerrero R, Hernández Caselles T, Martínez Barba E, et al. MITF induces escape from innate immunity in melanoma. J Exp Clin Cancer Res. 2021;40:117 pubmed publisher
  4. Crescitelli R, Lässer C, Jang S, Cvjetkovic A, Malmhäll C, Karimi N, et al. Subpopulations of extracellular vesicles from human metastatic melanoma tissue identified by quantitative proteomics after optimized isolation. J Extracell Vesicles. 2020;9:1722433 pubmed publisher
  5. Liu S, Liu Z, Chen F, Xu W, Yuan G. Adrenocorticotropic Hormone-Producing Paraganglioma With Low Plasma ACTH Level: A Case Report and Review of the Literature. Front Endocrinol (Lausanne). 2019;10:936 pubmed publisher
  6. Marotte L, Simon S, Vignard V, Dupré E, Gantier M, Cruard J, et al. Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytes. J Immunother Cancer. 2020;8: pubmed publisher
  7. Boscheinen J, Thomann S, Knipe D, Deluca N, Schuler Thurner B, Gross S, et al. Generation of an Oncolytic Herpes Simplex Virus 1 Expressing Human MelanA. Front Immunol. 2019;10:2 pubmed publisher
  8. Rapino F, Delaunay S, Rambow F, Zhou Z, Tharun L, de Tullio P, et al. Codon-specific translation reprogramming promotes resistance to targeted therapy. Nature. 2018;558:605-609 pubmed publisher
  9. Yang C, Lin S, Chiang C, Wu Y, H ng W, Chang C, et al. Loss of GPNMB Causes Autosomal-Recessive Amyloidosis Cutis Dyschromica in Humans. Am J Hum Genet. 2018;102:219-232 pubmed publisher
  10. Patwardhan A, Bardin S, Miserey Lenkei S, Larue L, Goud B, Raposo G, et al. Routing of the RAB6 secretory pathway towards the lysosome related organelle of melanocytes. Nat Commun. 2017;8:15835 pubmed publisher
  11. Miyashita H, Niwano H, Yoshida S, Hatou S, Inagaki E, Tsubota K, et al. Long-term homeostasis and wound healing in an in vitro epithelial stem cell niche model. Sci Rep. 2017;7:43557 pubmed publisher
  12. Cheuk S, Schlums H, Gallais Sérézal I, Martini E, Chiang S, Marquardt N, et al. CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin. Immunity. 2017;46:287-300 pubmed publisher
  13. Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol. 2017;30:79-107 pubmed publisher
  14. Xia Q, Wang Z, Chen N, Gan H, Teng X, Shi S, et al. Xp11.2 translocation renal cell carcinoma with NONO-TFE3 gene fusion: morphology, prognosis, and potential pitfall in detecting TFE3 gene rearrangement. Mod Pathol. 2017;30:416-426 pubmed publisher
  15. Kaji T, Yamasaki O, Takata M, Otsuka M, Hamada T, Morizane S, et al. Comparative study on driver mutations in primary and metastatic melanomas at a single Japanese institute: A clue for intra- and inter-tumor heterogeneity. J Dermatol Sci. 2017;85:51-57 pubmed publisher
  16. Yu L, Li J, Xu S, Navia Miranda M, Wang G, Duan Y. An Xp11.2 translocation renal cell carcinoma with SMARCB1 (INI1) inactivation in adult end-stage renal disease: a case report. Diagn Pathol. 2016;11:98 pubmed
  17. Lund A, Wagner M, Fankhauser M, Steinskog E, Broggi M, Spranger S, et al. Lymphatic vessels regulate immune microenvironments in human and murine melanoma. J Clin Invest. 2016;126:3389-402 pubmed publisher
  18. Nelson D, Jaber Hijazi F, Cole J, Robertson N, Pawlikowski J, Norris K, et al. Mapping H4K20me3 onto the chromatin landscape of senescent cells indicates a function in control of cell senescence and tumor suppression through preservation of genetic and epigenetic stability. Genome Biol. 2016;17:158 pubmed publisher
  19. Talar B, Gajos Michniewicz A, Talar M, Chouaib S, Czyz M. Pentoxifylline Inhibits WNT Signalling in ?-Cateninhigh Patient-Derived Melanoma Cell Populations. PLoS ONE. 2016;11:e0158275 pubmed publisher
  20. Kemper K, Krijgsman O, Kong X, Cornelissen Steijger P, Shahrabi A, Weeber F, et al. BRAF(V600E) Kinase Domain Duplication Identified in Therapy-Refractory Melanoma Patient-Derived Xenografts. Cell Rep. 2016;16:263-277 pubmed publisher
  21. Liu W, Meng Z, Liu H, Li W, Wu Q, Zhang X, et al. Hepatic epithelioid angiomyolipoma is a rare and potentially severe but treatable tumor: A report of three cases and review of the literature. Oncol Lett. 2016;11:3669-3675 pubmed
  22. Hahn S, Neuhoff A, Landsberg J, Schupp J, Eberts D, Leukel P, et al. A key role of GARP in the immune suppressive tumor microenvironment. Oncotarget. 2016;7:42996-43009 pubmed publisher
  23. Ertoy Baydar D, Kosemehmetoglu K, Aydin O, Bridge J, Buyukeren B, Aki F. Primary sclerosing epithelioid fibrosarcoma of kidney with variant histomorphologic features: report of 2 cases and review of the literature. Diagn Pathol. 2015;10:186 pubmed publisher
  24. Agaimy A, Specht K, Stoehr R, Lorey T, Märkl B, Niedobitek G, et al. Metastatic Malignant Melanoma With Complete Loss of Differentiation Markers (Undifferentiated/Dedifferentiated Melanoma): Analysis of 14 Patients Emphasizing Phenotypic Plasticity and the Value of Molecular Testing as Surrogate Diagnostic Marker. Am J Surg Pathol. 2016;40:181-91 pubmed publisher
  25. Galore Haskel G, Nemlich Y, Greenberg E, Ashkenazi S, Hakim M, Itzhaki O, et al. A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme. Oncotarget. 2015;6:28999-9015 pubmed publisher
  26. Kuroda N, Agatsuma Y, Tamura M, Martinek P, Hes O, Michal M. Sporadic renal hemangioblastoma with CA9, PAX2 and PAX8 expression: diagnostic pitfall in the differential diagnosis from clear cell renal cell carcinoma. Int J Clin Exp Pathol. 2015;8:2131-8 pubmed
  27. Woan K, Lienlaf M, Perez Villaroel P, Lee C, Cheng F, Knox T, et al. Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation. Mol Oncol. 2015;9:1447-1457 pubmed publisher
  28. Miracco C, Toscano M, Butorano M, Baldino G, Tacchini D, Barone A, et al. Unusual clear cell, lymphoplasmacyte-rich, dural-based tumor with divergent differentiation: a tricky case mimicking a meningioma. Hum Pathol. 2015;46:1050-6 pubmed publisher
  29. Wagner R, Luciani F, Cario André M, Rubod A, Petit V, Benzekri L, et al. Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo. J Invest Dermatol. 2015;135:1810-1819 pubmed publisher
  30. DiTommaso T, Cottle D, Pearson H, Schlüter H, Kaur P, Humbert P, et al. Keratin 76 is required for tight junction function and maintenance of the skin barrier. PLoS Genet. 2014;10:e1004706 pubmed publisher
  31. Liang N, Zhang C, Dill P, Panasyuk G, Pion D, Koka V, et al. Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex. J Exp Med. 2014;211:2249-63 pubmed publisher
  32. Shen Q, Rao Q, Xia Q, Yu B, Shi Q, Zhang R, et al. Perivascular epithelioid cell tumor (PEComa) with TFE3 gene rearrangement: clinicopathological, immunohistochemical, and molecular features. Virchows Arch. 2014;465:607-13 pubmed publisher
  33. Wang X, Bledsoe K, Graham R, Asmann Y, Viswanatha D, Lewis J, et al. Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma. Nat Genet. 2014;46:666-8 pubmed publisher
  34. Marie J, Kovacs D, Pain C, Jouary T, Cota C, Vergier B, et al. Inflammasome activation and vitiligo/nonsegmental vitiligo progression. Br J Dermatol. 2014;170:816-23 pubmed publisher
  35. Dziasko M, Armer H, Levis H, Shortt A, Tuft S, Daniels J. Localisation of epithelial cells capable of holoclone formation in vitro and direct interaction with stromal cells in the native human limbal crypt. PLoS ONE. 2014;9:e94283 pubmed publisher
  36. Ishida M, Iwai M, Yoshida K, Kagotani A, Okabe H. Signet-ring cell melanoma with sentinel lymph node metastasis: A case report with immunohistochemical analysis and review of the clinicopathological features. Oncol Lett. 2014;7:65-68 pubmed
  37. Locher H, Frijns J, Huisman M, Chuva de Sousa Lopes S. TUBB3: neuronal marker or melanocyte mimic?. Cell Transplant. 2014;23:1471-3 pubmed publisher
  38. Yasuno K, Nishiyama S, Kobayashi R, Yoshimura H, Takahashi K, Omachi T, et al. Proliferative lesions of intra-epidermal cytokeratin CAM5.2-positive cells in canine nipples. J Comp Pathol. 2014;150:18-26 pubmed publisher
  39. Frederick D, Piris A, Cogdill A, Cooper Z, Lezcano C, Ferrone C, et al. BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma. Clin Cancer Res. 2013;19:1225-31 pubmed publisher
  40. Chui J, Coroneo M, Tat L, Crouch R, Wakefield D, Di Girolamo N. Ophthalmic pterygium: a stem cell disorder with premalignant features. Am J Pathol. 2011;178:817-27 pubmed publisher
  41. Helmke B, Zahel T, Breinig M, Schirmacher P, Aulmann S, Kern M. Her2 overexpression is a rare event in anorectal melanoma. Melanoma Res. 2010;20:431-4 pubmed publisher
  42. Ryan P, Nguyen V, Gholoum S, Carpineta L, Abish S, Ahmed N, et al. Polypoid PEComa in the rectum of a 15-year-old girl: case report and review of PEComa in the gastrointestinal tract. Am J Surg Pathol. 2009;33:475-82 pubmed publisher